Preclinical models demonstrate that pulmonary vascular disease progression is mediated by increased elastolytic activity and extracellular matrix alterations that drive smooth muscle cell proliferation and migration.
No takes yet. Share an insight, caveat, or question.
Elastase inhibition warrants no clinical consideration yet; leaves open translation of rat and cell culture findings to human pulmonary vascular disease.
Marlene Rabinovitch (1991) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: